Spontaneous Haematomas of Psoas Occurring in Intensive Care

Spontaneous Haematomas of Psoas Occurring in Intensive Care: Incidence, Patient Characteristics and Treatment, a Retrospective Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03452631

Enrollment

Registered

2018-03-02

Start date

2017-10-01

Completion date

2017-12-31

Last updated

2022-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoas Hematomas

Keywords

Psoas hematomas

Brief summary

Psoas hematomas are a rare and potentially lethal pathology whose incidence in resuscitation is unknown. The pathophysiology of this pathology is not known to date.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Major patients * Psoas hematoma diagnosed during hospitalization

Exclusion criteria

* Refusal to participate in the study

Design outcomes

Primary

Measure	Time frame
Number of psoas hematomas	72 hours after admission to intensive care

Countries

France

Outcome results